These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 32300735

  • 1. Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials.
    Nielsen OH, Steenholdt C, Juhl CB, Rogler G.
    EClinicalMedicine; 2020 Mar; 20():100271. PubMed ID: 32300735
    [Abstract] [Full Text] [Related]

  • 2. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC, de Azevedo MFC, Carlos AS, Wada MY, Silva TVM, Feitosa FC.
    World J Gastroenterol; 2019 Mar 07; 25(9):1142-1157. PubMed ID: 30863001
    [Abstract] [Full Text] [Related]

  • 3. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R.
    Cochrane Database Syst Rev; 2019 Feb 07; 2(2):CD012730. PubMed ID: 30731030
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 6. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M, Taylor K, Akobeng AK, Thomas AG.
    Cochrane Database Syst Rev; 2014 Aug 01; 2014(8):CD010233. PubMed ID: 25081347
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate for induction of remission in ulcerative colitis.
    Chande N, Wang Y, MacDonald JK, McDonald JW.
    Cochrane Database Syst Rev; 2014 Aug 27; 2014(8):CD006618. PubMed ID: 25162749
    [Abstract] [Full Text] [Related]

  • 8. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
    Davies SC, Nguyen TM, Parker CE, MacDonald JK, Jairath V, Khanna R.
    Cochrane Database Syst Rev; 2019 Dec 12; 12(12):CD012804. PubMed ID: 31828765
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy and safety of combination therapy with infliximab for Crohn's disease: a systematic review and network meta-analysis.
    Han B, Tang D, Lv X, Li S, Fan J, Xu X, Zhang J, Xu S, Ye W, Huang Z, Zhan L, Lv X.
    Int J Colorectal Dis; 2023 Mar 27; 38(1):82. PubMed ID: 36971914
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
    Chen M, Feng Y, Liu W.
    Ann Palliat Med; 2021 Nov 27; 10(11):11821-11829. PubMed ID: 34872306
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P.
    Am J Gastroenterol; 2011 Apr 27; 106(4):630-42. PubMed ID: 21407186
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Solitano V, Vuyyuru SK, MacDonald JK, Zayadi A, Parker CE, Narula N, Peyrin-Biroulet L, Danese S, Feagan BG, Singh S, Ma C, Jairath V.
    J Crohns Colitis; 2023 Nov 24; 17(11):1800-1816. PubMed ID: 37317532
    [Abstract] [Full Text] [Related]

  • 13. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK.
    Cochrane Database Syst Rev; 2019 Aug 06; 8(8):CD010233. PubMed ID: 31425621
    [Abstract] [Full Text] [Related]

  • 14. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Townsend CM, Parker CE, MacDonald JK.
    Cochrane Database Syst Rev; 2016 Oct 26; 10(10):CD000545. PubMed ID: 27783843
    [Abstract] [Full Text] [Related]

  • 15. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Tsoulis DJ, MacDonald JK.
    Cochrane Database Syst Rev; 2013 Apr 30; (4):CD000545. PubMed ID: 23633304
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C, Fournier N, Pittet V, Dudler J, Michetti P.
    Digestion; 2017 Nov 30; 96(4):220-227. PubMed ID: 29065423
    [Abstract] [Full Text] [Related]

  • 17. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG, Macdonald JK.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD000544. PubMed ID: 23076890
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.
    Ben-Horin S, Novack L, Mao R, Guo J, Zhao Y, Sergienko R, Zhang J, Kobayashi T, Hibi T, Chowers Y, Peyrin-Biroulet L, Colombel JF, Kaplan GG, Chen MH.
    Gastroenterology; 2022 Feb 17; 162(2):482-494. PubMed ID: 34757139
    [Abstract] [Full Text] [Related]

  • 19. Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis.
    Hu Q, Tang XZ, Liu F, Liu DW, Cao B.
    Therap Adv Gastroenterol; 2023 Feb 17; 16():17562848231166227. PubMed ID: 37124368
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW, Bickston SJ.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD006893. PubMed ID: 18254120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.